Asset Intelligence / Hyperliquid Context
SPDR S&P Biotech ETF / BIOTECH
Archive-backed market intelligence for BIOTECH: every HIPERWIRE mover article tied to this asset, plus a client-refreshed live market panel.
BIOTECH tracks the XBI ETF, which represents the engine of medical innovation. It uses an equal-weighted approach to capture the biotechnology sector, providing high-growth exposure to smaller firms developing next-gen drugs and life-saving therapies.
Live Structure
Market Status
Loading current market structure...
- Buildervntl
- Categorystock
- Tracked Marketvntl:BIOTECH
- Latest Tweet—
No other live markets from this builder in the current screener.
No same-category alternatives are live in the current screener snapshot.
Archive Summary
Latest Archived Thesis
How to Trade SPDR S&P Biotech ETF (BIOTECH) on Hyperliquid
BIOTECH is a HIP-3 perpetual futures contract tracking the SPDR S&P Biotech ETF (XBI), an equal-weighted fund holding 151 biotechnology companies. It gives traders 24/7 leveraged exposure to the full spectrum of U.S. biotech, from clinical-stage startups to large-cap names like Moderna and Gilead. The perp is available on Hyperliquid with up to 20x leverage.
Background reading selected from this asset's symbol, builder context, and archived catalyst coverage.
HIP-3 Explained: Anyone Can Launch Hyperliquid Perps
HIP-3 lets anyone deploy a perpetual futures market on Hyperliquid — no approval needed. How builders launch markets, post stake, and earn fees.
Funding Rates Explained: A Trader's Guide (2026)
Funding rates decide if you pay or earn holding a perp position. How Hyperliquid's hourly funding works, reading rate signals, and cash-and-carry arbitrage.